A carregar...
Dermatomyositis autoantibodies: how can we maximize utility?
The past 15 years has seen significant advances in the characterization of myositis-specific autoantibodies (MSAs) and their associated phenotypes in patients with dermatomyositis (DM). As more careful studies are performed, it is clear that unique combinations of clinical and pathological phenotype...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033377/ https://ncbi.nlm.nih.gov/pubmed/33842654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-5175 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|